| human | Q5 |
| P6178 | Dimensions author ID | 01351530056.58 |
| P496 | ORCID iD | 0000-0002-7034-8091 |
| P3829 | Publons author ID | 2383318 |
| P1053 | ResearcherID | I-5892-2015 |
| P1153 | Scopus author ID | 22135728700 |
| P10861 | Springer Nature person ID | 01351530056.58 |
| P69 | educated at | Universidade Federal do Paraná | Q1232831 |
| Clinical Hospital of the Federal University of Paraná | Q10298532 | ||
| Paulista School of Medicine | Q107338977 | ||
| Wilmer Ophthalmological Institute | Q110966333 | ||
| Universidade Federal de São Paulo | Q4384447 | ||
| P108 | employer | Universidade Federal de São Paulo | Q4384447 |
| P734 | family name | Maia | Q21488838 |
| Maia | Q21488838 | ||
| Maia | Q21488838 | ||
| P735 | given name | Mauricio | Q2880923 |
| Mauricio | Q2880923 | ||
| P106 | occupation | researcher | Q1650915 |
| P5008 | on focus list of Wikimedia project | WikiProject Zika Corpus | Q54439832 |
| P21 | sex or gender | male | Q6581097 |
| Q40180049 | A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza B Virus Monoclonal Antibody, MHAB5553A, in Healthy Volunteers |
| Q46146057 | A multiplexed hybrid LC-MS/MS pharmacokinetic assay to measure two co-administered monoclonal antibodies in a clinical study |
| Q90873739 | A new dye based on anthocyanins from the acai fruit (Euterpe oleracea) for chromovitrectomy in humans: clinical trial results |
| Q35820384 | A predictive score for retinopathy of prematurity in very low birth weight preterm infants |
| Q39720763 | A therapeutic anti-VEGF antibody with increased potency independent of pharmacokinetic half-life |
| Q51451474 | ANATOMICAL AND FUNCTIONAL OUTCOMES OF SYMPTOMATIC IDIOPATHIC VITREOMACULAR TRACTION: A Natural History Study From the Pan American Collaborative Retina Study Group. |
| Q43246611 | Ability of new vital dyes to stain intraocular membranes and tissues in ocular surgery |
| Q35985939 | An Innovative Surgical Technique for Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigmented Epithelium in Yucatan Mini Pigs: Preliminary Results |
| Q46598026 | An intraocular dye solution based on lutein and zeaxanthin in a surrogate internal limiting membrane model: a Langmuir monolayer study. |
| Q60197382 | Analysis of Anthocyanins Extracted from the Acai Fruit (): A Potential Novel Vital Dye for Chromovitrectomy |
| Q30539151 | Analysis of a 23-gauge ultra high-speed cutter with duty cycle control |
| Q38158180 | Anterior-Segment Ocular Findings and Microphthalmia in Congenital Zika Syndrome |
| Q35151008 | Anti-VEGF for the management of diabetic macular edema |
| Q46211189 | Anti-neuropilin-1 (MNRP1685A): unexpected pharmacokinetic differences across species, from preclinical models to humans |
| Q28656427 | Arboviruses and the eye |
| Q34669943 | Association of age and macular pigment optical density using dual-wavelength autofluorescence imaging |
| Q50214872 | BILATERAL DIFFUSE UVEAL MELANOCYTIC PROLIFERATION ASSOCIATED WITH RENAL CANCER: THE IMPORTANCE OF INDOCYANINE GREEN ANGIOGRAPHY AND EARLY DIAGNOSIS. |
| Q34675149 | Bevacizumab for the management of diabetic macular edema |
| Q34983376 | Biochemical analysis and decomposition products of indocyanine green in relation to solvents, dye concentrations and laser exposure. |
| Q60197388 | COMPARISON OF 20-, 23-, AND 25-GAUGE AIR INFUSION FORCES |
| Q34200343 | Classifications of vitreomacular traction syndrome: diameter vs morphology. |
| Q43992259 | Color variation assay of the anthocyanins from Açai Fruit (Euterpe oleracea): a potential new dye for vitreoretinal surgery |
| Q51743500 | Comparing outcomes in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration treated with two different doses of primary intravitreal bevacizumab: results of the Pan-American Collaborative Retina Study Gro |
| Q50217317 | Comparing the mode of action of intraocular lutein-based dyes with synthetic dyes. |
| Q57454300 | Comparison of 577-nm Multispot and Standard Single-Spot Photocoagulation for Diabetic Retinopathy |
| Q60197387 | Comparison of a single intravitreal injection of bevacizumab versus triamcinolone acetonide as primary treatment for diffuse diabetic macular oedema |
| Q46732910 | Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up |
| Q43246129 | Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 months |
| Q42975585 | Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months |
| Q60197405 | Conceitos atuais e perspectivas na prevenção da degeneração macular relacionada à idade |
| Q46498845 | Contribution of Antibody Hydrodynamic Size to Vitreal Clearance Revealed through Rabbit Studies Using a Species-Matched Fab. |
| Q37997261 | Current concepts in vitreomacular traction syndrome |
| Q37872508 | Cytokines in neovascular age-related macular degeneration: fundamentals of targeted combination therapy |
| Q50225777 | Development and initial experience with a colored perfluorocarbon liquid for intraocular tamponade in vitreoretinal surgery. |
| Q52836562 | Development of a new tissue injector for subretinal transplantation of human embryonic stem cell derived retinal pigmented epithelium. |
| Q90353220 | Diathermy for 23-gauge sclerotomy: a functional and morphologic study to avoid ocular hypotony |
| Q60197395 | Difference Between Bevel-Up and Bevel-Down 23-Gauge One-Step Incisions: Analysis of Anterior Chamber Optical Coherence Tomography and IOP |
| Q46966177 | Drug Target Interference in Immunogenicity Assays: Recommendations and Mitigation Strategies |
| Q34522248 | Drusen detection by confocal aperture-modulated infrared scanning laser ophthalmoscopy |
| Q46895606 | Drusen measurements comparison by fundus photograph manual delineation versus optical coherence tomography retinal pigment epithelial segmentation automated analysis |
| Q37499549 | Dyes in ocular surgery: principles for use in chromovitrectomy |
| Q60197389 | ENDOPHTHALMITIS AFTER PARS PLANA VITRECTOMY |
| Q60197390 | Early Determinants of Death Due to Multiple Organ Failure After Noncardiac Surgery in High-Risk Patients |
| Q34468933 | Early sedation and clinical outcomes of mechanically ventilated patients: a prospective multicenter cohort study |
| Q60197391 | Effect of Needle Type and Injection Technique on Pain Level and Vitreal Reflux in Intravitreal Injection |
| Q43411400 | Effect of lens status in the surgical success of 23-gauge primary vitrectomy for the management of rhegmatogenous retinal detachment: the Pan American Collaborative Retina Study (PACORES) group results |
| Q46475809 | Effect of oxygenated intraocular irrigation solutions on the electroretinogram after vitrectomy |
| Q51754407 | Effect of tamoxifen on arterial microvascular anastomosis. |
| Q39095211 | Effect of vital dyes on retinal pigmented epithelial cell viability and apoptosis: implications for chromovitrectomy |
| Q58587296 | Effectiveness and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: A Real-World Experience |
| Q44839116 | Effects of indocyanine green injection on the retinal surface and into the subretinal space in rabbits |
| Q44839113 | Effects of intravitreal indocyanine green injection in rabbits |
| Q35953960 | Effects of intravitreal triamcinolone acetonide injection with and without preservative |
| Q50238520 | Effects of light exposure, pH, osmolarity, and solvent on the retinal pigment epithelial toxicity of vital dyes. |
| Q40220480 | Effects of subretinal injection of patent blue and trypan blue in rabbits |
| Q50471860 | Effects of subretinal injections of indocyanine green, trypan blue, and glucose in rabbit eyes. |
| Q50221435 | Efficacy of a lutein-based dye (Phacodyne™) for visualizing anterior capsulorhexis during cataract surgery by phacoemulsification. |
| Q45953773 | Electrical stimulation in normal and retinal degeneration (rd1) isolated mouse retina. |
| Q33304852 | Emerging pharmacotherapies for diabetic macular edema |
| Q50467609 | Endophthalmitis after 25-gauge pars plana vitrectomy. |
| Q46060828 | Evaluation of choroid and sclera early alterations in hypercholesterolemic rabbits: histologic and histomorphometric study |
| Q43184951 | Evaluation of early abnormalities of the sensory retina in a hypercholesterolemia experimental model: an immunohistochemical study |
| Q35679698 | Evaluation of the therapeutic results of actinic keratosis treated with topical 5% fluorouracil by reflectance confocal laser microscopy: preliminary study |
| Q41040127 | Experimental histopathological study on retinal and renal cellular response to intravitreous antiangiogenic drugs |
| Q33727213 | Experimental investigation of needles, syringes and techniques for intravitreal injections |
| Q46676350 | Fluid dynamics in three 25-gauge vitrectomy systems: principles for use in vitreoretinal surgery |
| Q35538034 | Fluidics comparison between dual pneumatic and spring return high-speed vitrectomy systems |
| Q36837215 | Fluidics in a dual pneumatic ultra high-speed vitreous cutter system |
| Q46298201 | Fluorescein angiography, optical coherence tomography, and histopathologic findings in a VEGF(165) animal model of retinal angiogenesis |
| Q27678647 | Generation and characterization of a unique reagent that recognizes a panel of recombinant human monoclonal antibody therapeutics in the presence of endogenous human IgG |
| Q40052055 | Glaucoma and Congenital Zika Syndrome |
| Q57077186 | Guidelines on Diabetic Eye Care |
| Q33563197 | Heavy silicone oil as a long-term endotamponade agent for complicated retinal detachments |
| Q40083775 | Historical aspects and evolution of the application of vital dyes in vitreoretinal surgery and chromovitrectomy |
| Q51694215 | Home-Based Pulmonary Rehabilitation for Subjects With COPD: A Randomized Study. |
| Q28223994 | INFANTS WITH CONGENITAL ZIKA SYNDROME AND OCULAR FINDINGS FROM SÃO PAULO, BRAZIL |
| Q60197384 | INTRAOCULAR PRESSURE ELEVATION AFTER UNCOMPLICATED PARS PLANA VITRECTOMY |
| Q57767977 | INTRAVITREAL BEVACIZUMAB FOR INFLAMMATORY CHOROIDAL NEOVASCULARIZATION |
| Q36080452 | INTRAVITREAL BEVACIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Results From the Pan-American Collaborative Retina Study Group (PACORES) at 24 Months of Follow-up |
| Q53490138 | INTRAVITREAL DEXAMETHASONE IMPLANT IN RETINITIS PIGMENTOSA-RELATED CYSTOID MACULAR EDEMA. |
| Q34863644 | In vivo detection of hESC-RPE cells via confocal near-infrared fundus reflectance |
| Q39348099 | In vivo, in vitro toxicity and in vitro angiogenic inhibition of sunitinib malate |
| Q36395170 | Incidence of anterior segment neovascularization during intravitreal treatment for macular edema secondary to central retinal vein occlusion |
| Q42995698 | Intravitreal Bevacizumab (Avastin(®)) for Diabetic Retinopathy at 24-months: The 2008 Juan Verdaguer-Planas Lecture |
| Q33902419 | Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture |
| Q46985103 | Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months follow-up |
| Q53167536 | Intravitreal bevacizumab for diabetic macular oedema: 5-year results of the Pan-American Collaborative Retina Study group. |
| Q45958318 | Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results. |
| Q43009206 | Intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration at twenty-four months: the Pan-American Collaborative Retina Study |
| Q38621559 | Intravitreal bevacizumab monotherapy in myopic choroidal neovascularisation: 5-year outcomes for the PAN-American Collaborative Retina Study Group |
| Q60197386 | Investigation of the retinal biocompatibility of acid violet for chromovitrectomy |
| Q37993467 | Ligand binding assays in the 21st century laboratory: recommendations for characterization and supply of critical reagents |
| Q30831967 | Lower exposure and faster clearance of bevacizumab in gastric cancer and the impact of patient variables: analysis of individual data from AVAGAST phase III trial |
| Q50426758 | Lutein and zeaxanthin toxicity with and without brilliant blue in rabbits. |
| Q50230490 | Lutein: a new dye for chromovitrectomy. |
| Q48469208 | Macular hole: 10 and 20-MHz ultrasound and spectral-domain optical coherence tomography |
| Q33588463 | Macular pigment optical density measured by dual-wavelength autofluorescence imaging in diabetic and nondiabetic patients: a comparative study. |
| Q54901311 | Managing macular hole associated with acute inflammatory Vogt-Koyanagi-Harada syndrome. |
| Q60197412 | Metrorrhagia after intravitreal injection of bevacizumab |
| Q39246924 | Migration, integration, survival, and differentiation of stem cell-derived neural progenitors in the retina in a pharmacological model of retinal degeneration |
| Q46679066 | Morphologic and clinical effects of subretinal injection of indocyanine green and infracyanine green in rabbits |
| Q47810162 | Multicenter, Randomized Clinical Trial to Assess the Effectiveness of Intravitreal Injections of Bevacizumab, Triamcinolone, or Their Combination in the Treatment of Diabetic Macular Edema |
| Q90432558 | New perspectives on macular hole surgery at three years of follow-up |
| Q46982408 | Non-contiguous recurrence or secondary choroidal melanoma following plaque radiotherapy |
| Q24291027 | Ocular Findings in Infants With Microcephaly Associated With Presumed Zika Virus Congenital Infection in Salvador, Brazil |
| Q52561024 | Ocular abnormalities in congenital Zika syndrome: are the ophthalmoscopic findings "the top of the iceberg"? |
| Q42929710 | Ocular pharmacology in the treatment of vitreous, retina and choroid diseases |
| Q24261103 | Ophthalmological findings in infants with microcephaly and presumable intra-uterus Zika virus infection |
| Q40052819 | Optical Coherence Tomography of Retinal Lesions in Infants With Congenital Zika Syndrome |
| Q57455811 | Optimizing hybrid LC-MS/MS binding conditions is critical: impact of biotransformation on quantification of trastuzumab |
| Q53626830 | Outcomes of cataract surgery in diabetic patients: results of the Pan American Collaborative Retina Study Group. |
| Q46982402 | Peripapillary haemorrhagic retinal pigment epithelium detachment following radial optic neurotomy |
| Q37830849 | Perspective on fluid and solid dynamics in different pars plana vitrectomy systems |
| Q45967035 | Pharmacokinetics and exposure-response analysis of RG7667, a combination of two anti-cytomegalovirus monoclonal antibodies, in a Phase 2a randomized trial to prevent cytomegalovirus infection in high-risk kidney transplant recipients. |
| Q38375170 | Pharmacokinetics of MHAA4549A, an Anti-Influenza A Monoclonal Antibody, in Healthy Subjects Challenged with Influenza A Virus in a Phase IIa Randomized Trial |
| Q44444048 | Pharmacokinetics of ranibizumab after intravitreal administration in patients with retinal vein occlusion or diabetic macular edema |
| Q35859879 | Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults |
| Q40083222 | Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge Model |
| Q44109810 | Posterior hyaloid detachment and internal limiting membrane peeling assisted by anthocyanins from acai fruit (Euterpe oleracea) and 10 other natural vital dyes: experimental study in cadaveric eyes |
| Q37286996 | Preclinical pharmacokinetics of MHAA4549A, a human monoclonal antibody to influenza A virus, and the prediction of its efficacious clinical dose for the treatment of patients hospitalized with influenza A. |
| Q35620033 | Preoperative and intraoperative prognostic factors of epiretinal membranes using chromovitrectomy and internal limiting membrane peeling |
| Q60197414 | Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema |
| Q45958323 | Primary intravitreal bevacizumab for diffuse diabetic macular edema: the Pan-American Collaborative Retina Study Group at 24 months. |
| Q28295656 | Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up |
| Q60197413 | Primary intravitreal bevacizumab for the management of pseudophakic cystoid macular edema |
| Q33599492 | Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion |
| Q40037684 | Quantitative Assessment of Microstructural Changes of the Retina in Infants With Congenital Zika Syndrome |
| Q60197396 | Raman spectroscopy for differential diagnosis of endophthalmitis and uveitis in rabbit iris in vitro |
| Q46159585 | Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo |
| Q55167518 | Reply to Hunsberger and Memoli, "Efficacy Analysis in Healthy-Volunteer Influenza Challenge Trials: Intention To Treat". |
| Q50235294 | Residual internal limiting membrane after epiretinal membrane peeling: results of the Pan-American Collaborative Retina Study Group. |
| Q33581923 | Retinal and ocular toxicity in ocular application of drugs and chemicals--part I: animal models and toxicity assays |
| Q37779189 | Retinal and ocular toxicity in ocular application of drugs and chemicals--part II: retinal toxicity of current and new drugs |
| Q34272339 | Retinal biocompatibility of brilliant blue g with deuterated water for chromovitrectomy |
| Q44839137 | Retinal pigment epithelial abnormalities after internal limiting membrane peeling guided by indocyanine green staining |
| Q34723229 | Retinal pigmented epithelial cells cytotoxicity and apoptosis through activation of the mitochondrial intrinsic pathway: role of indocyanine green, brilliant blue and implications for chromovitrectomy |
| Q34772724 | Retinal prosthesis for the blind |
| Q24289643 | Risk Factors Associated With the Ophthalmoscopic Findings Identified in Infants With Presumed Zika Virus Congenital Infection |
| Q30490738 | SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB. |
| Q33675159 | Sclerochorioretinal abnormalities in hypercholesterolemic rabbits treated with rosiglitazone |
| Q36173110 | Small-Gauge Pars Plana Vitrectomy for the Management of Symptomatic Posterior Vitreous Detachment after Phacoemulsification and Multifocal Intraocular Lens Implantation: A Pilot Study from the Pan-American Collaborative Retina Study Group |
| Q50226141 | Soluble lutein in combination with brilliant blue as a new dye for chromovitrectomy. |
| Q50229469 | Staining properties of brilliant blue depending on different incubation times and solvents in humans. |
| Q46713828 | Subretinal bevacizumab detection after intravitreous injection in rabbits |
| Q43235429 | Subretinal brilliant blue G migration during internal limiting membrane peeling. |
| Q37053158 | Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: improved survival when implanted as a monolayer |
| Q46856461 | Subretinal injection of preservative-free triamcinolone acetonide and supernatant vehicle in rabbits: an electron microscopy study |
| Q46935579 | Subretinal trypan blue migration during epiretinal membrane peeling |
| Q51759335 | Survey on physicians' knowledge of sepsis: do they recognize it promptly? |
| Q48492974 | Susac syndrome: diverse clinical findings and treatment |
| Q34608306 | Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD |
| Q46147265 | Technique of intravitreal drug injection for therapy of vitreoretinal diseases |
| Q59813666 | The Question of a Role for Statins in Age-Related Macular Degeneration |
| Q38616527 | The Use of Vital Dyes during Vitreoretinal Surgery - Chromovitrectomy |
| Q34997545 | The use of vital dyes in ocular surgery |
| Q37359674 | Therapeutic monoclonal antibodies in ophthalmology |
| Q46905269 | Thermal damage to a light probe using a xenon light source |
| Q46927800 | Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy |
| Q37303225 | Twelve-Month Follow-Up of Dexamethasone Implants for Macular Edema from Various Diseases in Vitrectomized and Nonvitrectomized Eyes. |
| Q37203832 | Two Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Studies To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza A Virus Monoclonal Antibody, MHAA4549A, in Healthy Volunteers |
| Q50249540 | Use of lutein and zeaxanthin alone or combined with Brilliant Blue to identify intraocular structures intraoperatively. |
| Q33358799 | Vital dyes and light sources for chromovitrectomy: comparative assessment of osmolarity, pH, and spectrophotometry |
| Q36792441 | Vital dyes for chromovitrectomy |
| Q43184948 | Vital dyes in chromovitrectomy |
| Q38176655 | Vital dyes in ophthalmology: a chemical perspective |
| Q36461879 | Vitreomacular traction syndrome. |
| Q35566121 | Vitreomacular traction syndrome: postoperative functional and anatomic outcomes |
| Q47204847 | Weight gain measured at 6 weeks after birth as a predictor for severe retinopathy of prematurity: study with 317 very low birth weight preterm babies |
| Q38156828 | Zika virus and the eye. |
| Q22330676 | Zika virus in Brazil and macular atrophy in a child with microcephaly |
| Q24576005 | Zika: neurological and ocular findings in infant without microcephaly |
| Q54310198 | [Intravitreal implantation of Ozurdex® chronic delivery system for management of macular edema related to retinitis pigmentosa: case report]. |
| Q30238484 | [Ocular manifestations of Zika virus: What we do and do not know]. |
Search more.